Coronary artery disease is one of the l wide. lipoprotein(a) [Lp (a)] is a cholesterol rich plasma lipoprotein Its structure and composition closely resembles low density lipoproteins (LDL). Elevated Lp (a) is the most common familial lipoprotein disorder in patients with premature Coronary Artery Disease (CAD). Objective: To study the pattern of plasma LP(a) levels in Sudanese patients who presented with coronary artery disease [CAD]. Material and Methods: This is a case control study. 
Introduction
Coronary artery disease [CAD] is one the leading causes of death for both men and women world wide 1 . CAD risk increases with age, obesity and certain diseases such as diabetes, hypertension, high serum cholesterol level, high level of low-density lipoprotein (LDL) in the blood and with certain social h smoking 2 . Inherited factors may also increase the likelihood of developing CAD 3 . Lipoprotein a [Lp (a)] is a cholesterol rich plasma lipoprotein which was first identified as plasma antigen in 1963 by Berg 4 . Its structure and composition closely resemble low density lipoproteins (LDL).
The plasma concentration of Lp (a) is mostly genetically determined 5 . E is the most common familial lipoprotein disorder in patients with premature CAD 6 . Lp(a) are associated with significantly increased risk in subjects under 60 years but may be of less significance in the elderly patients 7 increases with age and in patients with renal insufficiency, nephritic syndrome and kidney transplantation 8 . However, in a brief study done in Sudan, the levels of lipoproteins were found to be relatively low/normal in patients with chronic renal diseases and that was attributed to diet and possibly genetic factors Group I showed significantly higher levels of the three biochemical markers (Lp (a), cholesterol and LDL) than group II (Table 2 ). Lp (a) was found to be more prevalent in patients with CAD than cholesterol and LDL [47% and 27% respectively], however there was a strong correlation between the high level of the three markers as 75% of the patients with high cholesterol and LDL has also high level of Lp(a) ( Tables 2 and 3 ). There was high prevalence of elevated Lp(a) levels in female gender (71%). It is also high in patients blew 60 years of age (70%) and in those with more than one risk factor (73%) [ Tables 4 and 5 ].
The most prevalent risk factors were hypertension and diabetes while smoking is the least frequent one [ Our study demonstrated that 20% of the patients with CAD, who had no other risk factors had significantly high Lp(a) levels (table 4). It also showed that the prevalence of high Lp(a) in group I is more than that of cholesterol and LDL (table3). These findings may suggest a role for Lp(a) as an independent risk factor which keeps with the work of Sandkamp 12 . The same result was observed in the Framingham Offspring Study 7 However, these results contrast, the Physicians Health Study and Quebec Cardiovascular Study 13, 14 . These differences in reports could be attributed to differences in sample collection, storage and type of Lp(a) assays. A recent metaanalysis 15 , including 27 published prospective studies (18 population-based and 9 with pre existing CAD) and involving 5436 cases with mean follow up of 10 years, demonstrated a moderate and independent association of Lp(a) and CAD.
Conclusion
This study suggests that Lp (a) level is significantly high in patients with CAD and those blew 60years of age. It is associated with other risk factors and correlates with Cholestrol and LDL levels. The sample size is rather small to suggest that it is an independent risk factor (although it was significantly high in 20% of the patients who had no other risk factor).
Further studies are needed to address the significance of Lp(a) in patients with CAD blew 60 years of age who has no other risk factors.
